SCHEMBL18896291

SCHEMBL18896291

N#Cc1ccccc1CSS

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
SMN1; SMN2 Q16637 6/20 0.46
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALOX15 P16050 1/20 0.43
ATM Q13315 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TP53 P04637 1/20 0.42
CYP19A1 P11511 1/20 0.42
HSD11B1 P28845 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.40
CTSB P07858 1/20 0.40
TSHR P16473 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL515046 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL515045 0.79 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL5697502 0.76 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL9567419 0.76 CYP19A1 (0.46) ALDH1A1SMN1; SMN2NPC1RAB9AHSD17B10
SCHEMBL2154210 0.75 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL2153612 0.75 CYP19A1 (0.48) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL6690636 0.75 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL10953659 0.73 CYP1A2 (0.56) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL19356915 0.73 CYP19A1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9ANPSR1
SCHEMBL3987067 0.72 CYP19A1 (0.43) ALDH1A1SMN1; SMN2NPC1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9662335-B2 Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors INCYTE HOLDINGS CORPORATION (US) 2017-05-30 US disclosed